SeaStar Medical Holding Corporation Total Assets
SeaStar Medical Holding Corporation total assets. Based on the latest financial reports, SeaStar Medical Holding Corporation (ICU) holds total assets worth $8.65 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see SeaStar Medical Holding Corporation market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of SeaStar Medical Holding Corporation (2020–2025)
Total assets of SeaStar Medical Holding Corporation from 2020 to 2025. This chart illustrates how SeaStar Medical Holding Corporation's total assets have evolved over time, based on quarterly financial data. See SeaStar Medical Holding Corporation stock quote for real-time trading data and today's change.
SeaStar Medical Holding Corporation - Asset Composition Analysis
SeaStar Medical Holding Corporation Total Assets Breakdown (December 2025)
SeaStar Medical Holding Corporation total assets breakdown as of December 2025. SeaStar Medical Holding Corporation's total assets of $8.65 Million consist of 95.9% current assets and 4.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 84.6% |
| Accounts Receivable | $237.00K | 1.7% |
| Inventory | $66.00K | 0.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2025)
This chart illustrates how SeaStar Medical Holding Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of SeaStar Medical Holding Corporation to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SeaStar Medical Holding Corporation's current assets represent 95.9% of total assets in 2025, a decrease from 99.9% in 2020.
- Cash Position: Cash and equivalents constituted 84.6% of total assets in 2025, down from 96.5% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 1.7% of total assets.
SeaStar Medical Holding Corporation Competitors by Total Assets
Key competitors of SeaStar Medical Holding Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL
|
Belgium | €37.05 Million |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $11.72 Billion |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA
|
USA | $1.14 Billion |
|
Gempharmatech Co. Ltd. A
SHG:688046
|
China | CN¥2.80 Billion |
|
Vor Biopharma Inc
NASDAQ:VOR
|
USA | $481.05 Million |
|
Inventiva S.A
PA:IVA
|
France | €249.51 Million |
|
Sunmax Biotechnology Co Ltd
TWO:4728
|
Taiwan | NT$1.90 Billion |
|
Apnimed, Inc. Common Stock
NASDAQ:APMD
|
USA | $342.63 Million |
SeaStar Medical Holding Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.89 | 1.52 | 2.25 |
| Quick Ratio | 1.87 | 1.50 | 2.25 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.88 Million | $2.60 Million | $347.57K |
SeaStar Medical Holding Corporation - Advanced Valuation Insights
This section examines the relationship between SeaStar Medical Holding Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.11 |
| Latest Market Cap to Assets Ratio | 0.62 |
| Asset Growth Rate (YoY) | 204.0% |
| Total Assets | $14.16 Million |
| Market Capitalization | $8.81 Million USD |
Valuation Analysis
Below Book Valuation: The market values SeaStar Medical Holding Corporation's assets below their book value (0.62x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: SeaStar Medical Holding Corporation's assets grew by 204.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for SeaStar Medical Holding Corporation (2020–2025)
The table below shows the annual total assets of SeaStar Medical Holding Corporation from 2020 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $14.16 Million | +203.95% |
| 2024-12-31 | $4.66 Million | +32.59% |
| 2023-12-31 | $3.51 Million | +15.64% |
| 2022-12-31 | $3.04 Million | +403.81% |
| 2021-12-31 | $603.00K | -79.27% |
| 2020-12-31 | $2.91 Million | -- |
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperi… Read more